(2025). Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumors. Immunotherapy Advances.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Preclinical Assessment of MAGE-A4-specific TCR-NK Cells Against Solid Tumors."
Immunotherapy Advances 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Preclinical Assessment of MAGE-A4-specific TCR-NK Cells Against Solid Tumors."
Immunotherapy Advances, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.